A J Schlabach

1.3k total citations
13 papers, 1.2k citations indexed

About

A J Schlabach is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, A J Schlabach has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Virology and 6 papers in Molecular Biology. Recurrent topics in A J Schlabach's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and Viral gastroenteritis research and epidemiology (2 papers). A J Schlabach is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and Viral gastroenteritis research and epidemiology (2 papers). A J Schlabach collaborates with scholars based in United States and Switzerland. A J Schlabach's co-authors include Arthur Weissbach, Arthur H. Bolden, Bertold Fridlender, Jon H. Condra, Vinod Sardana, Donald J. Graham, L Gotlib, Mohindar S. Poonian, Jill Wolfgang and William J. Long and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

A J Schlabach

13 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A J Schlabach United States	12	717	474	438	137	118	13	1.2k
P F Lin United States	15	388 0.5×	344 0.7×	347 0.8×	85 0.6×	75 0.6×	24	910
Gilles Mirambeau France	18	1.1k 1.5×	421 0.9×	268 0.6×	124 0.9×	188 1.6×	29	1.4k
Mohinder Singh United Kingdom	13	904 1.3×	339 0.7×	167 0.4×	53 0.4×	101 0.9×	21	1.2k
Karsten Henco Germany	19	673 0.9×	204 0.4×	189 0.4×	133 1.0×	135 1.1×	30	1.5k
Thierry Huet France	13	423 0.6×	713 1.5×	482 1.1×	296 2.2×	120 1.0×	18	1.2k
Stephen Oroszlan United States	19	828 1.2×	374 0.8×	285 0.7×	163 1.2×	235 2.0×	28	1.6k
Richard Benarous France	16	572 0.8×	300 0.6×	263 0.6×	242 1.8×	55 0.5×	37	992
Corrado Gurgo United States	13	363 0.5×	362 0.8×	260 0.6×	174 1.3×	162 1.4×	24	840
Patrick Kanda United States	22	915 1.3×	576 1.2×	241 0.6×	199 1.5×	214 1.8×	46	1.7k
P L Callahan United States	9	662 0.9×	437 0.9×	496 1.1×	332 2.4×	129 1.1×	9	1.3k

Countries citing papers authored by A J Schlabach

Since Specialization

Citations

This map shows the geographic impact of A J Schlabach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A J Schlabach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A J Schlabach more than expected).

Fields of papers citing papers by A J Schlabach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A J Schlabach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A J Schlabach. The network helps show where A J Schlabach may publish in the future.

Co-authorship network of co-authors of A J Schlabach

This figure shows the co-authorship network connecting the top 25 collaborators of A J Schlabach. A scholar is included among the top collaborators of A J Schlabach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A J Schlabach. A J Schlabach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Sardana, Vinod, A J Schlabach, Pia Graham, et al.. (1994). Human Immunodeficiency Virus Type 1 Protease Inhibitors: Evaluation of Resistance Engendered by Amino Acid Substitutions in the Enzyme's Substrate Binding Site. Biochemistry. 33(8). 2004–2010. 42 indexed citations

Byrnes, V W, Emilio A. Emini, William A. Schleif, et al.. (1994). Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. Antimicrobial Agents and Chemotherapy. 38(6). 1404–1407. 57 indexed citations

Byrnes, V W, Vinod Sardana, William A. Schleif, et al.. (1993). Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors. Antimicrobial Agents and Chemotherapy. 37(8). 1576–1579. 95 indexed citations

Sardana, Vinod, Emilio A. Emini, L Gotlib, et al.. (1992). Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.. Journal of Biological Chemistry. 267(25). 17526–17530. 95 indexed citations

Condra, Jon H., Emilio A. Emini, L Gotlib, et al.. (1992). Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors. Antimicrobial Agents and Chemotherapy. 36(7). 1441–1446. 71 indexed citations

Condra, Jon H., Vinod Sardana, Joanne E. Tomassini, et al.. (1990). Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cells.. Journal of Biological Chemistry. 265(4). 2292–2295. 43 indexed citations

Cordingley, Michael G., Robert L. LaFemina, P L Callahan, et al.. (1990). Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.. Proceedings of the National Academy of Sciences. 87(22). 8985–8989. 161 indexed citations

Schlabach, A J, et al.. (1983). Scale‐up of Chick Cell Growth on Microcarriers in Fermenters for Vaccine Production. Annals of the New York Academy of Sciences. 413(1). 332–339. 11 indexed citations

Schlabach, A J, D. Martínez, Anjalie Field, & A. A. Tytell. (1979). Resistance of C58 mice to primary systemic herpes simplex virus infection: macrophage dependence and T-cell independence. Infection and Immunity. 26(2). 615–620. 20 indexed citations

10.

Citarella, R. V., Rolf Müller, A J Schlabach, & Arthur Weissbach. (1972). Studies on Vaccinia Virus-Directed Deoxyribonucleic Acid Polymerase. Journal of Virology. 10(4). 721–729. 43 indexed citations

11.

Schlabach, A J, Bertold Fridlender, Arthur H. Bolden, & Arthur Weissbach. (1971). DNA-dependent DNA polymerases from HeLa cell nuclei II. Template and substrate utilization. Biochemical and Biophysical Research Communications. 44(4). 879–885. 188 indexed citations

12.

Weissbach, Arthur, A J Schlabach, Bertold Fridlender, & Arthur H. Bolden. (1971). DNA Polymerases from Human Cells. Nature New Biology. 231(23). 167–170. 234 indexed citations

13.

Poonian, Mohindar S., A J Schlabach, & Arthur Weissbach. (1971). Covalent attachment of nucleic acids to agarose for affinity chromatography. Biochemistry. 10(3). 424–427. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact